SCHEMBL17807302

SCHEMBL17807302

c1ccc(-n2c3ccccc3c3c4oc5ccc(-n6c7ccccc7c7c8oc9ccc(-n%10c%11ccccc%11c%11c%12oc%13ccccc%13c%12ccc%11%10)cc9c8ccc76)cc5c4ccc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ATM Q13315 1/20 0.42
ALDH1A1 P00352 7/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
HSD17B10 Q99714 3/20 0.41
TSHR P16473 2/20 0.41
POLB P06746 2/20 0.41
BRCA1 P38398 1/20 0.41
PPARG P37231 3/20 0.37
RXFP1 Q9HBX9 3/20 0.37
NR2E3 Q9Y5X4 3/20 0.37
NCOR2 Q9Y618 3/20 0.37
MAPT P10636 3/20 0.35
HPGD P15428 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17807287 0.99 KDM4E (0.41) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL16483801 0.96 KDM4E (0.41) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL16171139 0.96 KDM4E (0.44) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL16283030 0.95 KDM4E (0.46) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL15137662 0.95 KDM4E (0.46) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL9890026 0.95 MAPT (0.40) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL17246134 0.95 MAPT (0.40) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL17807278 0.95 ALDH1A1 (0.36) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL16484951 0.94 KDM4E (0.43) KDM4EL3MBTL1ATMALDH1A1MEN1
SCHEMBL16483846 0.94 KDM4E (0.43) KDM4EL3MBTL1ATMALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160163996-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-09 US disclosed
US-20160163996-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160163996-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME LEF1, PIEZO1, EPCAM KDM4E 2661/4885L3MBTL1 1590/4885ATM 3988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.